Curriculum Vitaes
  1. Researcher Search Results
  2. yamada harumoto

yamada harumoto

  (山田 治基)

Profile Information

Affiliation
School of Medicine, Faculty of Medicine, Fujita Health University
Degree
博士(医学)(慶應義塾大学)
J-GLOBAL ID
200901009942077470
researchmap Member ID
1000289390

Misc.

 152
  • Daiki Ikeda, Hiroshi Ageta, Kunihiro Tsuchida, Harumoto Yamada
    BIOMARKERS, 18(7) 565-572, Nov, 2013  
    Objective: We performed comprehensive proteomic analyses of articular cartilage by using the isobaric tags for relative and absolute quantitation (iTRAQ) method, and searched for candidate biomarkers for osteoarthritis (OA). Methods: Articular cartilage was collected from patients with OA or femoral neck fracture for the control group. Molecular variations were detected by the iTRAQ method, and quantitative analyses were performed by western blot. Results: Using the iTRAQ method, we identified 76 proteins with different expression levels in OA patients and the control group. Among these proteins, we selected LECT2 (leukocyte cell-derived chemotaxin-2), BAALC (brain and acute leukemia, cytoplasmic), and PRDX6 (peroxiredoxin-6), which had not been reported as biomarkers for OA. Conclusions: Use of these proteins in combination with conventional OA biomarkers may better reflect the grade and prognosis of OA.
  • Daiki Ikeda, Hiroshi Ageta, Kunihiro Tsuchida, Harumoto Yamada
    BIOMARKERS, 18(7) 565-572, Nov, 2013  
    Objective: We performed comprehensive proteomic analyses of articular cartilage by using the isobaric tags for relative and absolute quantitation (iTRAQ) method, and searched for candidate biomarkers for osteoarthritis (OA). Methods: Articular cartilage was collected from patients with OA or femoral neck fracture for the control group. Molecular variations were detected by the iTRAQ method, and quantitative analyses were performed by western blot. Results: Using the iTRAQ method, we identified 76 proteins with different expression levels in OA patients and the control group. Among these proteins, we selected LECT2 (leukocyte cell-derived chemotaxin-2), BAALC (brain and acute leukemia, cytoplasmic), and PRDX6 (peroxiredoxin-6), which had not been reported as biomarkers for OA. Conclusions: Use of these proteins in combination with conventional OA biomarkers may better reflect the grade and prognosis of OA.
  • 山田治基
    【健康・栄養科学シリーズ】人体の構造と機能及び疾病の成り立ち 各論 改訂第2版, Sep, 2013  
  • Makoto Nishio, Arihiko Kanaji, Keisuke Horiuchi, Atsushi Funayama, Teruyo Oishi, Yoshiaki Toyama, Harumoto Yamada
    Current Orthopaedic Practice, 24(5) 552-556, Sep, 2013  
  • 大石央代, 金治有彦, 早川和恵, 前原一之, 山田治基
    中部整災誌, 56(1) 118-118, Sep, 2013  
More

Books and Other Publications

 6
More

Presentations

 153

Professional Memberships

 5

作成した教科書、教材、参考書

 1
  • 件名（英語）
    -
    終了年月日（英語）
    2013
    概要（英語）
    標準整形外科学　第１版　第７章　関節の病態、病理
To the list screen